| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $16.79B | $15.92B | $15.14B |
| YoY Revenue Growth % | +5.4% | +5.1% | — |
| Gross Profit | — | — | — |
| Gross Margin % | — | — | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $3.12B | $3.41B | $4.41B |
| Operating Margin % | 18.6% | 21.4% | 29.1% |
| Net Income (GAAP) | $2.64B | $2.89B | $3.74B |
| EBITDA (Normalized) | $3.72B | $3.99B | $4.96B |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $6.71B | $6.60B | $6.54B |
| Capital Expenditures (CapEx) | $755.4M | $716.4M | $681.3M |
| Free Cash Flow (FCF) | $5.96B | $5.88B | $5.86B |
| FCF Margin % | 35.5% | 37.0% | 38.7% |
| Return on Invested Capital (ROIC %) | 11.4% | 12.2% | 18.6% |
| Cash & Short-Term Equivalents | $1.38B | $811.0M | — |
| Total Debt (Short + Long Term) | $7.39B | $8.40B | $7.24B |
| Total Stockholders' Equity | $15.53B | $14.50B | $14.86B |